SCHEMBL3564084

SCHEMBL3564084

Cc1c(O)c2ccccc2n1S(=O)(=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SRC P12931 2/20 0.51
PTGDR2 Q9Y5Y4 2/20 0.49
PTGDR Q13258 1/20 0.49
AGTR1 P30556 3/20 0.49
HTR6 P50406 7/20 0.48
AVPR1A P37288 1/20 0.47
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
FABP3 P05413 1/20 0.45
FABP4 P15090 1/20 0.45
FABP5 Q01469 1/20 0.45
ACLY P53396 1/20 0.44
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3562004 0.85 PTGDR2 (0.51) SRCPTGDR2PTGDRAGTR1HTR6
SCHEMBL19605706 0.83 HTR6 (0.50) SRCPTGDR2PTGDRAGTR1HTR6
SCHEMBL3565477 0.83 ACLY (0.57) SRCPTGDR2PTGDRHTR6LMNA
SCHEMBL3558278 0.83 PTGDR2 (0.68) SRCPTGDR2PTGDRHTR6LMNA
SCHEMBL3563869 0.83 HTR6 (0.50) SRCPTGDR2PTGDRHTR6LMNA
SCHEMBL16655202 0.81 HTR6 (0.47) SRCPTGDR2PTGDRAGTR1HTR6
SCHEMBL3557075 0.81 HTR6 (0.64) SRCPTGDR2PTGDRHTR6
SCHEMBL3556363 0.80 HTR6 (0.49) HTR6FABP3FABP4FABP5ACLY
SCHEMBL28485336 0.80 HTR6 (0.48) SRCPTGDR2PTGDRHTR6ACLY
SCHEMBL3557485 0.79 AGTR1 (0.58) SRCAGTR1HTR6LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
US-7507835-B2 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LTD. (IN) 2009-03-24 US disclosed
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2006-08-03 US disclosed
CN-1720227-A N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LTD (IN) 2006-01-11 CN disclosed
EP-1567492-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES Suven Life Sciences Limited (IN) 2005-08-31 EP disclosed
WO-2004048328-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT SRC 158/4885PTGDR2 829/4885PTGDR 726/4885
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT SRC 158/4885PTGDR2 829/4885PTGDR 726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.